Armata Pharmaceuticals Inc.
ARMP | AMEX
$4.38
+$0.12 (+2.82%)
Sep 22, 2026, 12:57 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -192.18M | -282.61M | -173.8M | -46.9M | -25.71M | -426K | -18.92M | -41.36M | -67.04M | -79.58M | -69.05M | -59.51M | -36.97M | -42.63M | -36.92M | -32.65M | -29.46M | -26.43M | -23.16M | -23.73M | -24.08M | -22.6M |
Depreciation & Amortization | 2.86M | 1.61M | 1.53M | 1.49M | 1.44M | 1.39M | 1.33M | 1.24M | 1.15M | 1.06M | 972K | 924K | 929K | 896K | 892K | 924K | 1.01M | 1.11M | 1.17M | 1.17M | 1.12M | 1.1M |
Stock-Based Compensation | 5.72M | 2.9M | 2.61M | 2.33M | 2.38M | 3.14M | 2.89M | 2.73M | 1.69M | 615K | 938K | 1.56M | 2.78M | 3.47M | 3.11M | 2.95M | 2.58M | 2.53M | 2.88M | 3.08M | 3.27M | 3.27M |
Other Working Capital | -362K | 817K | -1.08M | 1.56M | -508K | 1.22M | 1.66M | -1.06M | 515K | -3.9M | -10.36M | -14.81M | -18.32M | -14.01M | -5.49M | -4.93M | -1.26M | -1.16M | -3.18M | -602K | -494K | -953K |
Other Non-Cash Items | 158.41M | 253.45M | 145.31M | 16.25M | -6.75M | -37.04M | -20.75M | 2.39M | 23.5M | 37.61M | 25.5M | 14.8M | -1.66M | 4.38M | 1.22M | -2.01M | -3.95M | -3.95M | -3.89M | -491K | 390K | 531K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.86M | 3.86M | 3.86M | 3.86M | n/a | n/a | n/a | 3.22M | 3.22M | 3.22M | 2.64M | -1.02M | -1.02M | -1.02M |
Change in Working Capital | -230K | 684K | -1.41M | -190K | -2.94M | -1.6M | -2.1M | -2.73M | -1.7M | -4.01M | -9.65M | -11.44M | -15.53M | -12.65M | -776K | -3.04M | 1.37M | 1.9M | -3.22M | -284K | 124K | -801K |
Operating Cash Flow | -25.42M | -23.97M | -25.76M | -27.02M | -31.58M | -34.55M | -37.55M | -37.73M | -38.55M | -40.44M | -47.42M | -49.8M | -50.45M | -46.54M | -32.48M | -30.59M | -25.23M | -21.62M | -23.58M | -21.28M | -20.2M | -19.51M |
Capital Expenditures | -374K | -506K | -542K | -413K | -511K | -1.73M | -1.88M | -4.36M | -7.53M | -6.38M | -8.14M | -5.29M | -3.07M | -3.99M | -2.21M | -2.89M | -2.18M | -1.24M | -1.3M | -1.44M | -941K | -1.02M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10K | 10K | 10K | 10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -374K | -506K | -542K | -413K | -511K | -1.73M | -1.88M | -4.35M | -7.52M | -6.37M | -8.13M | -5.29M | -3.07M | -3.99M | -2.21M | -2.89M | -2.18M | -1.24M | -1.3M | -1.44M | -941K | -1.02M |
Debt Repayment | 40M | 15M | 25M | -9.89M | -24.89M | -24.89M | n/a | 34.89M | 59.69M | 59.32M | 54.03M | 54.03M | 29.23M | 29.59M | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K |
Common Stock Repurchased | -32K | -32K | -46K | -46K | -75K | -75K | -61K | -104K | -43K | -43K | -43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -63K | -63K | n/a | 34.89M | 34.89M | 34.89M | 34.89M | n/a | n/a | n/a | n/a | -500K | -446K | -375K | -375K | 207K | 153K | 82K | -887K | -537K | -450K | 268K |
Financial Cash Flow | 44.15M | 16.27M | 25.61M | 24.95M | 9.93M | 10.01M | 34.96M | 34.92M | 59.78M | 59.33M | 53.99M | 53.53M | 28.76M | 28.98M | 44.02M | 51.55M | 51.61M | 51.57M | 25.52M | 18.91M | 18.89M | 19.38M |
Net Cash Flow | 18.35M | -8.2M | -693K | -2.48M | -22.17M | -26.26M | -4.23M | -6.92M | 13.95M | 12.75M | -1.57M | -1.56M | -24.76M | -21.54M | 9.32M | 18.07M | 24.2M | 28.71M | 639K | -3.81M | -2.25M | -1.15M |
Free Cash Flow | -25.79M | -24.47M | -26.31M | -27.43M | -32.09M | -36.28M | -39.43M | -42.09M | -46.08M | -46.82M | -55.57M | -55.09M | -53.52M | -50.52M | -34.69M | -33.49M | -27.41M | -22.86M | -24.88M | -22.72M | -21.14M | -20.53M |
Adj. Free Cash Flow | -31.51M | -27.38M | -28.92M | -29.76M | -34.47M | -39.42M | -42.32M | -44.82M | -47.77M | -47.44M | -56.51M | -56.65M | -56.3M | -53.99M | -37.8M | -36.44M | -29.98M | -25.39M | -27.76M | -25.8M | -24.41M | -23.8M |
Maintenance CapEx | -374K | -357K | -393K | -264K | -22K | -1.39M | -1.29M | -1.37M | -4.88M | -3.73M | -5.74M | -4.83M | -1.81M | -1.58M | 426.6K | -483.4K | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | -149K | -149K | -149K | -489K | -340K | -590K | -2.99M | -2.65M | -2.65M | -2.4M | -455K | -1.27M | -2.4M | -2.64M | -2.41M | -2.18M | -1.24M | -1.3M | -1.44M | -941K | -1.02M |
Owner Earnings | -25.79M | -24.32M | -26.16M | -27.28M | -31.6M | -35.94M | -38.84M | -39.1M | -43.43M | -44.17M | -53.17M | -54.64M | -52.25M | -48.12M | -32.05M | -31.08M | -25.23M | -21.62M | -23.58M | -21.28M | -20.2M | -19.51M |
Add to Watchlist
Select watchlists to add or remove ARMP